Expert Discusses State of Immunotherapy in Breast Cancer Subtypes – OncLive
OncLive |
Expert Discusses State of Immunotherapy in Breast Cancer Subtypes
OncLive Adams: Combining immunotherapy with other targeted therapies, such as chemotherapies and radiation treatments, is probably going to be the future of breast cancer. [This is] because the response rate to single-agent immunotherapy remains low … |
